BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27408882)

  • 1. (18)F-FDG PET/CT Imaging of Primary Hepatic Neuroendocrine Tumor.
    Mitamura K; Yamamoto Y; Tanaka K; Sanomura T; Murota M; Nishiyama Y
    Asia Ocean J Nucl Med Biol; 2015; 3(1):58-60. PubMed ID: 27408882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary hepatic neuroendocrine tumor -
    Rao YY; Zhang HJ; Wang XJ; Li MF
    World J Clin Cases; 2021 Aug; 9(22):6450-6456. PubMed ID: 34435011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A first described chest wall metastasis from colon cancer demonstrated with (18)F-FDG PET/CT.
    Jiang L; Gao Y; Sheng S; Xu M; Lu L; Lu H
    Hell J Nucl Med; 2011; 14(3):316-7. PubMed ID: 22087459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
    Sampathirao N; Basu S
    J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
    Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
    Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report: Primary hepatic neuroendocrine tumor: two cases report with literature review.
    Tang Y; Chen X; Lu X; Yuan Z; Yang Y; Qiu C; Li H
    Front Oncol; 2023; 13():1225583. PubMed ID: 37601674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
    Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
    Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment of primary hepatic neuroendocrine tumor diagnosed by Al
    Zhang Z; Li H
    Front Med (Lausanne); 2023; 10():1256176. PubMed ID: 38076257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of metabolic characteristics and viability of lipiodolized hepatocellular carcinomas using 18F-FDG PET/CT.
    Kim HO; Kim JS; Shin YM; Ryu JS; Lee YS; Lee SG
    J Nucl Med; 2010 Dec; 51(12):1849-56. PubMed ID: 21098794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI and FDG PET/CT findings of hepatic epithelioid hemangioendothelioma.
    Dong A; Dong H; Wang Y; Gong J; Lu J; Zuo C
    Clin Nucl Med; 2013 Feb; 38(2):e66-73. PubMed ID: 22996250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.
    Thapa P; Ranade R; Ostwal V; Shrikhande SV; Goel M; Basu S
    Nucl Med Commun; 2016 Oct; 37(10):1030-7. PubMed ID: 27243215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malignant tumor with false negative 18F-FDG PET image].
    Dong MJ; Lin XT; Zhao J; Guan YH; Zuo CT; Chen X; Dai JZ; Jiang BD
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):713-7. PubMed ID: 17274383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missed causative tumors in diagnosing tumor-induced osteomalacia with (18)F-FDG PET/CT: a potential pitfall of standard-field imaging.
    Kaneuchi Y; Hakozaki M; Yamada H; Hasegawa O; Tajino T; Konno S
    Hell J Nucl Med; 2016; 19(1):46-8. PubMed ID: 26929940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A Case of Hepatectomy for Primary Hepatic Neuroendocrine Tumor, Preoperatively Diagnosed with Hepatocellular Carcinoma].
    Tani N; Hori T; Iimori N; Sakimura C; Tendo M; Nakata B; Ishikawa T; Hirakawa K
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):2050-2052. PubMed ID: 33468797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case of Ewing Sarcoma of the Mandible on
    Takami Y; Aga F; Mitamura K; Norikane T; Okuda H; Yamamoto Y; Miyake M; Nishiyama Y
    Asia Ocean J Nucl Med Biol; 2020; 8(1):84-87. PubMed ID: 32064289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic and functional changes in nontumorous liver tissue after radiofrequency ablation in an in vivo model: comparison of 18F-FDG PET/CT, MRI, ultrasound, and CT.
    Vogt FM; Antoch G; Veit P; Freudenberg LS; Blechschmid N; Diersch O; Bockisch A; Barkhausen J; Kuehl H
    J Nucl Med; 2007 Nov; 48(11):1836-44. PubMed ID: 17942811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary hepatic neuroendocrine tumor: A case report and literature review.
    Song JE; Kim BS; Lee CH
    World J Clin Cases; 2016 Aug; 4(8):243-7. PubMed ID: 27574614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?
    Has Simsek D; Kuyumcu S; Turkmen C; Sanlı Y; Aykan F; Unal S; Adalet I
    J Nucl Med; 2014 Nov; 55(11):1811-7. PubMed ID: 25315243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.